glutathione disulfide nov-002 Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy and glutamic acid Glutathione Disulfide | C20H32N6O12S2 |
Glutathione Disulfide C20H32N6O12S2 CID 65359 PubChem Sigma Aldrich Glutathione Reductase human, CAS 9001 48 3, buffered aqueous solution, 10 units mg protein, recombinant, expressed in E. coli 500 ug Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications Signal Transduction and Targeted Therapy The glutathione disulfide mimetic NOV 002 inhibits cyclophosphamide induced hematopoietic and immune suppression by reducing oxidative stress ScienceDirect
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


